Cargando…

Anti-HIV activity of drugs that stimulate cholesterol efflux

Detalles Bibliográficos
Autores principales:	Morrow, Matthew P, Mujawar, Zahedi A, Bukrinsky, Michael I
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1716863/ http://dx.doi.org/10.1186/1742-4690-3-S1-P42

Ejemplares similares

Human immunodeficiency virus impairs reverse cholesterol transport from macrophages
por: Mujawar, Zahedi, et al.
Publicado: (2006)

HIV hijacks cholesterol transporter ABCA1 to get access to cellular cholesterol
por: Bukrinsky, Michael, et al.
Publicado: (2009)

Human Immunodeficiency Virus Impairs Reverse Cholesterol Transport from Macrophages
por: Mujawar, Zahedi, et al.
Publicado: (2006)

HIV-1 Nef targets calnexin: a novel mechanism behind Nef effects on host cell and viral proteins
por: Jennelle, Lucas, et al.
Publicado: (2013)

P02.97. Lipoic acid supplementation induces a transient stress response and improves episodic memory and cholesterol efflux in humans
por: Keith, D, et al.
Publicado: (2012)

Critical role of calnexin in Nef-mediated inactivation of ABCA1
por: Jennelle, Lucas, et al.
Publicado: (2011)

New Clues to Understanding HIV Nonprogressors: Low Cholesterol Blocks HIV Trans Infection
por: Prasad, Vinayaka R., et al.
Publicado: (2014)

Dual anti-HSV and anti-HIV activity of the lantibiotic Labyrinthopeptin A1
por: Férir, Geoffrey, et al.
Publicado: (2014)

Targeted cholesterol efflux
por: Fang, Longhou, et al.
Publicado: (2013)

Evaluation of anti-viral activity of Jatropha curcas leaf extracts against potentially drug-resistant HIV isolates
por: Dahake, Ritwik, et al.
Publicado: (2012)

Effect of nanoencapsulation on the phenomenon of drug interaction between anti-M.avium drug, rifabutin and anti-HIV drug, ritonavir by employing poly (lactide-co-glycolide) nanoparticles
por: Grewal, Tapinder, et al.
Publicado: (2012)

Anti-HIV and immune modulating activities of IND02
por: Biedma, ME, et al.
Publicado: (2012)

Screening of some savannah plants for antiretroviral (ANTI-HIV) activity
por: Mukhtar, MD, et al.
Publicado: (2009)

Recombinant soluble CCR5 AND CXCR4 chemokine receptors as anti-HIV drug targets
por: Kurbatska, Victoria, et al.
Publicado: (2010)

P60. Microtubule-depolymerising agents used in antibody-drug-conjugates induce anti-tumour immunity by stimulation of dendritic cells
por: Martin, K, et al.
Publicado: (2014)

Forced primer selection modulates HIV-1 replication and stability of the PBS
por: Ni, Na, et al.
Publicado: (2006)

In vitro anti-HIV activity of crude extracts from Tinospora cordifolia
por: Estari, Mamidala, et al.
Publicado: (2012)

Human paraoxonase 1 overexpression in mice stimulates HDL cholesterol efflux and reverse cholesterol transport
por: Ikhlef, Souade, et al.
Publicado: (2017)

The evolution of HIV-1 subtypes and disease progression among adults on anti-retroviral drugs in Northern Tanzania
por: Shao, E, et al.
Publicado: (2012)

Lignosulfonic acid exhibits broad-spectrum anti-HIV and anti-HSV activity and has potential for microbicidal applications
por: Férir, Geoffrey, et al.
Publicado: (2014)

Effect of HIV on production of anti-viral factors by HIV-specific CD4+ T cells
por: Hioe, Catarina, et al.
Publicado: (2006)

Molecular Mechanisms of Cellular Cholesterol Efflux
por: Phillips, Michael C.
Publicado: (2014)

Intracellular selection of E. coli tRNALys, 3 as the primer for HIV-1 replication
por: McCulley, Anna, et al.
Publicado: (2006)

P15-28. Attitudes and awareness of HIV vaccine research in HIV uninfected MSM in four US cities: Rochester, Boston, San Francisco and Philadelphia
por: Alexander, SB, et al.
Publicado: (2009)

Cross-reactive neutralizing activity in HIV-1 infected injecting drug users
por: Euler, Z, et al.
Publicado: (2012)

QSAR of anti-inflammatory drugs
por: Khayrullina, Veronica R, et al.
Publicado: (2010)

Drug interactions in the elderly HIV-infected patient
por: Coroiu, C, et al.
Publicado: (2010)

P17-16. Anti-Langerin-HIV Gag p24 fusion protein targeting Langerhans cells as a new anti-HIV vaccine strategy
por: Culina, S, et al.
Publicado: (2009)

Efficacy of non-steroidal anti-inflammatory drug monotherapy in children with systemic juvenile idiopathic arthritis
por: Riebschleger, Meredith P, et al.
Publicado: (2012)

Is extended resistance to the historical antiretroviral drugs & drug classes still a risk factor for HIV progression?
por: Zaccarelli, M, et al.
Publicado: (2010)

Anti-inflammatory effect of procalcitonin on in vitro LPS-stimulated human PBMC
por: Foca, A, et al.
Publicado: (2010)

Impact of hepatic venous oxygen efflux and carotid blood flow on the difference between mixed and central venous oxygen saturation
por: Correa, T, et al.
Publicado: (2011)

P18-13 LB. Immunogenicity of an autologous dendritic cell anti-HIV therapy in HIV-1 infected individuals
por: Yassine Diab, B, et al.
Publicado: (2009)

Serum cholesterol level: is it a marker of sepsis?
por: Abraham, B, et al.
Publicado: (2005)

Neutralizing anti-HIV antibodies develop in a humanized mouse model of HIV-1 infection
por: Seung, E, et al.
Publicado: (2012)

MAP kinase inhibitors stimulate T cell and anti-tumor activity in combination with blockade of the PD-L1/PD-1 interaction
por: Irving, Bryan A, et al.
Publicado: (2013)

Predictors of response and anti-TNF drugs comparative efficacy
por: Canhão, Helena, et al.
Publicado: (2011)

PA01.80. The review of herbal anti-allergy and anti-histaminic drugs
por: Kalaskar, Sneha, et al.
Publicado: (2012)

PRO 2000, a broadly active anti-HIV sulfonated compound, inhibits viral entry by multiple mechanisms
por: Huskens, Dana, et al.
Publicado: (2010)

Cholesterol efflux pathways, inflammation, and atherosclerosis
por: Groenen, Anouk G., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_skcmoagjschvocn4eu7obr27ev